Stock Events

Stock Events

Farmaceutica Remedia. 

lei0
2
+lei0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

14
SEP
Dividend Ex
Increased
 
30
SEP
Dividend Payment
Increased
 
14
SEP 27
Dividend Ex
Estimated
 
30
SEP 27
Dividend Payment
Estimated
 

Dividends

0%Dividend Yield
Sep 25
lei0.04
Sep 24
lei0.05
Sep 23
lei0.05
Jul 22
lei0.05
Jun 21
lei0.15
10Y Growth
N/A
5Y Growth
-23.23%
3Y Growth
-7.17%
1Y Growth
N/A

Financials

1.16%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.07BRevenue
24.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0M8I.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sanofi
SNY
Mkt Cap115.14B
Sanofi operates in the pharmaceutical sector, producing medications that may directly compete with Farmaceutica Remedia's product offerings.
Novartis
NVS
Mkt Cap293.34B
Novartis is a global healthcare company that manufactures drugs that could be in direct competition with those of Farmaceutica Remedia.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a large pharmaceutical company whose extensive range of medications competes with Farmaceutica Remedia's products.
Merck
MRK
Mkt Cap294.39B
Merck produces pharmaceuticals that compete in the same therapeutic areas as Farmaceutica Remedia.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline, a leading drug manufacturer, competes in various pharmaceutical niches that overlap with Farmaceutica Remedia's market.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie operates in the pharmaceutical industry, offering products that compete with Farmaceutica Remedia's range.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson offers a broad array of healthcare products that compete across the same sectors as Farmaceutica Remedia.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb is involved in the discovery, development, and marketing of drugs that compete with Farmaceutica Remedia.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca engages in the development of pharmaceutical products that could directly compete with Farmaceutica Remedia.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.65B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, competing in some of the same markets as Farmaceutica Remedia.

About

Show more...
CEO
ISIN
RORMAHACNOR2

Listings

LSE
GB
0M8I.LSE

0 Comments

Share your thoughts

FAQ

What is Farmaceutica Remedia. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Farmaceutica Remedia. stocks are traded under the ticker 0M8I.LSE.
What is Farmaceutica Remedia. revenue for the last year?▼
Farmaceutica Remedia. revenue for the last year amounts to 2.07B RON.
What is Farmaceutica Remedia. net income for the last year?▼
0M8I.LSE net income for the last year is 24.01M RON.
Does Farmaceutica Remedia. pay dividends?▼
Yes, 0M8I.LSE dividends are paid annual. The last dividend per share was 0.04 RON. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Farmaceutica Remedia. located?▼
Farmaceutica Remedia. operates in the Other sector.
When did Farmaceutica Remedia. complete a stock split?▼
Farmaceutica Remedia. has not had any recent stock splits.